Obstetrics and Gynecology

The obstetrics and gynecology drugs market size was USD 13,089.39 Million in 2021 and is expected to register a revenue CAGR of 7.5% during the forecast period, according to latest analysis by Emergen Research. Increasing incidence of menopausal disorders, Polycystic Ovary Syndrome (PCOS), and other diseases resulting in rising demand for obstetrics and gynecology drugs is a key factor projected to support market revenue growth between 2021 and 2030.

https://www.emergenresearch.com/request-sample/1389